Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays in China

NEW YORK – Twist Bioscience and China's Berry Genomics on Monday announced a partnership on next-generation sequencing target enrichment and library preparation tools.

Under their agreement, the firms will work together to develop new research and in vitro diagnostic NGS panels for inherited diseases.

Berry Genomics will also offer Twist's NGS panels for cancer diagnosis.

Financial and other details of the deal were not disclosed.

South San Francisco, California-based Twist offers NGS-based genotyping assays using its synthetic oligonucleotides to capture target sequences. NGS products became the company's top revenue generator in the company's first quarter of fiscal year 2021, which ended Dec. 31, 2020.

Last year, Berry Genomics partnered with cancer genomics firm Personalis to facilitate the latter company's expansion into China. Berry also has a partnership on clinical sequencing with Illumina.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.